Continued studies will deepen scientists’ understanding of virus-host interactions at the molecular level and also pave the way for developing better drugs to fight emerging viruses.

Flexible, high-throughput proteomics approach identifies protein modifications related to pancreatic stress and insulin production.

Scientists map how transitions from day to night control gene regulatory networks in cyanobacteria, revealing key orchestrators of metabolic switching.

Scientists uncover how cyanobacteria's circadian cycle controls carbon and energy metabolism, increasing carbon dioxide-to-bioproducts yields.

PNNL is hosting a scientific conference focused directly on understanding and predicting the collection of an organism’s traits.

Circadian rhythms of blue-green microbes offer new window into predictive phenomics—how to predict and control the traits of an organism.

Over the next four years, PNNL and University of Arizona will develop open-source computational tools to better identify and characterize the viruses associated with the human microbiome.

Armed with some of the world’s most advanced instrumentation, researchers at PNNL are working to analyze huge amounts of data and uncover hidden biological connections.

This week at AAAS, PNNL scientists discuss phenomics and the factors that influence DNA instructions to bring about the world around us.

A potential quantum advantage for fluid dynamics simulations from molecular to atmospheric scales with a new formula for success.

A new report details the potential for floating offshore wind to lower energy costs and enhance the resilience of the nation’s western grid.

CACTUS provides AI-powered cheminformatics for autonomous science.

A new analysis shows how renewable energy sources like solar, wind and hydropower respond to climate patterns, and how utilities can use this data to save money and invest in energy storage.

PNNL scientists use proteomics to unveil how high-density lipoproteins protect against cholesterol accumulation in the artery wall.

Scientists are using artificial intelligence and powerful computing to sculpt new molecules in an effort to treat disease.

Computing and artificial intelligence aid scientists who seek to understand function-driven design and control of biological systems.

PNNL researchers co-organized a workshop on fusion commercialization with partners from industry and academia

Klickitat Valley Health's fuel cell and microgrid project boosts rural healthcare, enhancing energy resilience and sustainability for social equity.

University of Washington Professor David Baker won the 2024 Nobel Prize in Chemistry for computational protein design.